aspergillus niger prolyl endoprotease

Allergenexperimental

Clinical trial activity

1 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2008 (NCT00810654)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetImmunity, desensitized

    Immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • aspergillus niger prolyl endoprotease

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00810654Phase 1/Phase 2 (Phase 2)May 1, 2008DSM, Free University of Amsterdam, Leiden University, University of Amsterdam
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
DSMFor profit1012008
Free University of AmsterdamAcademic/Hospital1012008
Leiden UniversityAcademic/Hospital1012008
University of AmsterdamAcademic/Hospital1112008
4 organizations
Page 1 / 1